Investor Relations |
We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put OPKO Health, Inc.'s financial performance into perspective.
Events
|
Citi 2012 Global Healthcare Conference
|
Stock Information
Latest News
OPKO Health Receives Important U.S. Patent Allowance Read more
OPKO Health Enters into License Agreement with International Health Technology for Next Generation Prostate Cancer Biomarker Panel Read more
OPKO Health Receives Important U.S. Patent Allowance Read more
OPKO Health Announces the Start of Phase 3 Clinical Trials of Rolapitant for the Prevention of CINV Read more
More News



